Dr. Sankaran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Avenue
Boston, MA 02115Phone+1 617-355-6000
Summary
- Dr. Vijay Sankaran is a pediatric hematologist/oncologist in Boston, MA and is affiliated with multiple hospitals in the area, including Boston Children's Hospital, Dana-Farber Cancer Institute, Brigham and Women's Hospital, and the Beth Israel Deaconess Hospital. He received his medical degree from Harvard Medical School and has been in practice 12 years. He is experienced in pediatric hematology/oncology, including in thalassemia, sickle cell disease, bone marrow failure syndromes, genetic predisposition to blood cancers, and other disorders impacting hematopoiesis.
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2013 - 2015
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2010 - 2013
- Harvard Medical SchoolClass of 2010
Certifications & Licensure
- MA State Medical License 2013 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- Evolution of myeloproliferative neoplasms from normal blood stem cells.Sahand Hormoz, Vijay G Sankaran, Ann Mullally
Haematologica. 2024-12-05 - Author Correction: Genetic drivers and cellular selection of female mosaic X chromosome loss.Aoxing Liu, Giulio Genovese, Yajie Zhao, Matti Pirinen, Seyedeh M Zekavat
Nature. 2024-12-03 - Genetics of Latin American Diversity Project: Insights into population genetics and association studies in admixed groups in the Americas.Victor Borda, Douglas P Loesch, Bing Guo, Roland Laboulaye, Diego Veliz-Otani
Cell Genomics. 2024-11-13
Press Mentions
- A Universal Gene Therapy for Diamond-Blackfan Anemia Is Poised for Clinical TestingNovember 21st, 2024
- How a Leukemia Hijacks the Genes Needed by Blood Stem CellsDecember 19th, 2022
- What Caused the Blood Malignancies Linked to Gene Therapy for Sickle Cell Disease?February 15th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: